The implications of zinc therapy in combating the COVID-19 global pandemic
N Samad, TE Sodunke, AR Abubakar… - Journal of …, 2021 - Taylor & Francis
The global pandemic from COVID-19 infection has generated significant public health
concerns, both health-wise and economically. There is no specific pharmacological antiviral …
concerns, both health-wise and economically. There is no specific pharmacological antiviral …
[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
The rise of SARS-CoV-2 variants and the role of convalescent plasma therapy for management of infections
Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …
Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …
quickly spread globally. Several treatments have been proposed, many of which have …
[HTML][HTML] Bioeconomy during the COVID-19 and perspectives for the post-pandemic world: Example from EU
E Woźniak, A Tyczewska - EFB Bioeconomy Journal, 2021 - Elsevier
The COVID-19 pandemic has had a significant impact on human lives around the world. A
report from the World Health Organization (WHO) dated 10 May 2021 indicates that the …
report from the World Health Organization (WHO) dated 10 May 2021 indicates that the …
[HTML][HTML] Roles of existing drug and drug targets for COVID-19 management
AG Ayele, EF Enyew, ZD Kifle - Metabolism Open, 2021 - Elsevier
In December 2019, a highly transmissible, pneumonia epidemic caused by a novel
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in …
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in …
[HTML][HTML] Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore …
This present study reports some natural products and one hydroxamic acid synthetic
compound which were previously reported as matrix metalloproteinase-9 (MMP-9) inhibitors …
compound which were previously reported as matrix metalloproteinase-9 (MMP-9) inhibitors …
[PDF][PDF] Convalescent plasma therapy for COVID-19: lessons from SARS-CoV, MERS-CoV, and H1N1 infection
P Hosseini, H Rahimi, MM Najafabadi, A Ghorbani… - infection, 2021 - academia.edu
The global widespread mortality after the emergence of SARS-CoV-2infection in China, has
become a critical concern all around the world. Convalescent plasma (CP) therapy is one of …
become a critical concern all around the world. Convalescent plasma (CP) therapy is one of …
COVID-19 pandemic and the convalescent plasma therapy: possible benefits and risks
R Noor, N Tasnim, C Saha - Current clinical microbiology reports, 2021 - Springer
Purpose of Review COVID-19 pandemic has been the major threat to the global public
health for a year (last of 2019–till date); and unfortunately, there is still as no specific antiviral …
health for a year (last of 2019–till date); and unfortunately, there is still as no specific antiviral …
Convalescent plasma: an evidence-based old therapy to treat novel coronavirus patients
Abstract Novel Coronavirus (nCoV-2019) is a highly infectious viral outbreak that has so far
infected more than 110 million people worldwide. Fast viral transmission and high infection …
infected more than 110 million people worldwide. Fast viral transmission and high infection …